Channels - Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment

Similar Items: Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment

Quick Look
Use of Wearable Technology for Measuring and Characterizing Sedentary Behavior in People With Mild Cognitive Impairment and Dementia: Systematic Review
Quick Look
A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
Quick Look
Associations among mild behavioral impairment, cognition, and brain pathology in preclinical autosomal dominant Alzheimer's disease
Quick Look
Vascular cognitive impairment and dementia drug‐development pipeline 2025
Quick Look
Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
Quick Look
The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias
Quick Look
Advances in pharmacotherapy for vascular cognitive impairment and vascular dementia: An update of 2025
Quick Look
Longitudinal changes in DTI‐ALPS and choroid plexus volume relative to CSF biomarkers during lecanemab treatment in mild cognitive impairment: A pilot study
Quick Look
Regional amyloid PET asymmetry and long‐term clinical trajectory in mild cognitive impairment
Quick Look
A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment
Quick Look
Virtual reality-based cognitive assessment tools for mild cognitive impairment screening: comparison with traditional paper-and-pencil-based cognitive assessment tools
Quick Look
Glymphatic clearance as revealed by diffusion tensor imaging along the perivascular space (DTI‐ALPS) is associated with Alzheimer's disease neuropathology and periodic rsEEG alpha rhythms in mild cognitive impairment participants
Quick Look
Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum
Quick Look
Prevalence of Lewy body pathology and phenotypic associations in patients with mild cognitive impairment: Evidence from the Interceptor study
Quick Look
Alteration of glucose neurometabolism and brain morphology in mild behavioral impairment: a neuroimaging study on cognitively healthy individuals
Quick Look
A diagnostic plasma omics‐biomarker for Alzheimer's disease informed by microglial single‐cell transcriptomics: A pilot study
Quick Look
Mid‐ and late‐life depression increases risk of Alzheimer's disease and related dementias in veterans
Quick Look
Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
Quick Look
APOE ε4 and Alzheimer's disease biomarkers in an American Indian community
Quick Look
Real‐time digital assessment of sleep–cognition dynamics in dementia care dyads
Quick Look
CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
Quick Look
A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
Quick Look
Biomarkers of Sarcopenia: Current Status and Future Perspectives
Quick Look
Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature